Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.

Publikation

Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.

Wissenschaftlicher Artikel/Review - 11.05.2022

Fischer Tim, El Baz Yassir, Graf Nicole, Wildermuth Simon, Leschka Sebastian, Kleger Gian-Reto, Pietsch Urs, Frischknecht Manuel, Scanferla Giulia, Strahm Carol, Wälti Stephan, Dietrich Tobias, Albrich Werner

Zitation

Fischer T, El Baz Y, Graf N, Wildermuth S, Leschka S, Kleger G, Pietsch U, Frischknecht M, Scanferla G, Strahm C, Wälti S, Dietrich T, Albrich W. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics (Basel) 2022; 12

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Diagnostics (Basel) 2022; 12

Veröffentlichungsdatum

11.05.2022

ISSN (Druck)

2075-4418

Kurzbeschreibung/Zielsetzung

COVID-19 superinfection by Aspergillus (COVID-19-associated aspergillosis, CAPA) is increasingly observed due to increased awareness and use of corticosteroids. The aim of this study is to compare clinical and imaging features between COVID-19 patients with and without associated pulmonary aspergillosis.